Description General description (2R,5R)-(+)-2-tert-Butyl-3-methyl-5-benzyl-4-imidazolidinone is a chiral imidazolidinone organocatalyst, developed by MacMillan and co-workers.[3] Packaging 1 g in glass bottle 500 mg in glass insert Application Used in the 1,4-addition of electron-rich benzenes to unsaturated aldehydes, and the asymmetric hydride reduction of α,β-unsaturated aldehydes.[1][2] Features and Benefits Advantages of MacMillan imidazolidinone organocatalysts:[3] • Superior enantiocontrol in numerous transformations • High activities at low catalyst loadings • Extraordinary functional group tolerance Legal Information U.S. Pat. 6,369,243 and related patents apply. For research purposes only.